BUD FLANAGAN LEUKAEMIA FUND LIMITED
Supporting various institutions in carrying out research into the causes, diagnosis and treatment of Leukaemia and the relief of those suffering from the disease.
Objects
(1) THE RELIEF OF PERSONS SUFFERING FROM LEUKAEMIA AND ALLIED DISEASES.(11) THE PROMOTION OF CLINICAL RESEARCH INTO THE TREATMENT AND POSSIBLE CURE OF LEUKAEMIA AND ALLIED DISEASES. (111) THE RELIEF OF POVERTY AND DISTRESS AMONG THE BENEFICIARIES AND THEIR FAMILIES AND DEPENDANTS.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit of £1,139 for the year ended 31 December 2025, resulting in a slight decrease in total net assets to £772,246. The trustees confirm that free reserves stood at £142,246, which they consider sufficient to meet current commitments and pursue activities for the foreseeable future. The charity maintains adequate resources to continue in operational existence on a going concern basis.
What the accounts disclose
“It is a policy of the charity that sufficient reserves are maintained to meet its current commitments and to pursue its activities for the foreseeable future.” — page 4
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 2
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 5
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 5
Property (HM Land Registry)
Trustees
- Geraldine Smith
- Kim Anthonia Smith
- MARTIN JOHN KING
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £28k | £29k |
| 31/12/2024 | £31k | £32k |
| 31/12/2023 | £25k | £28k |
| 31/12/2022 | £25k | £16k |
| 31/12/2021 | £29k | £25k |
Common questions
Is BUD FLANAGAN LEUKAEMIA FUND LIMITED financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit of £1,139 for the year ended 31 December 2025, resulting in a slight decrease in total net assets to £772,246. The trustees confirm that free reserves stood at £142,246, which they consider sufficient to meet current commitments and pursue activities for the foreseeable future. The charity maintains adequate resources to continue in operational existence on a going concern basis. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BNA CHARITABLE INCORPORATED ORGANISATION | 2 | £28k |
| THE BARBOUR FOUNDATION | 2 | £10k |
| THE FIDELITY UK FOUNDATION | 1 | £94k |
| THE PENNIES FOUNDATION | 1 | £44k |
| THE 29TH MAY 1961 CHARITY | 1 | £30k |
| THE SYNCONA FOUNDATION | 1 | £20k |
| THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION | 1 | £17k |
| THE ROAN CHARITABLE TRUST | 1 | £15k |
Charities like this
- THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
- LEUKAEMIA & MYELOMA RESEARCH UK LTD
- LEUKAEMIA CARE
- CURE LEUKAEMIA
- MELANOMA-ME FOUNDATION
- LYMPHOMA ACTION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| BUD FLANAGAN LEUKAEMIA FUND LIMITED | £28k | — | 0 | unclear | — | no doubt |
| THE CHILDREN'S CANCER AND LEUKAEMIA GROUP | £5.5m | — | — | below | — | no doubt |
| LEUKAEMIA & MYELOMA RESEARCH UK LTD | £554k | — | 0 | unclear | — | noted |
| LEUKAEMIA CARE | £2.5m | — | — | above | — | no doubt |
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| MELANOMA-ME FOUNDATION | £161k | — | 0 | above | — | no doubt |